These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 17513600

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
    Takata K, Morishige K, Takahashi T, Hashimoto K, Tsutsumi S, Yin L, Ohta T, Kawagoe J, Takahashi K, Kurachi H.
    Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
    [Abstract] [Full Text] [Related]

  • 4. Fasudil inhibits prostate cancer-induced angiogenesis in vitro.
    Chen W, Mao K, Hua-Huy T, Bei Y, Liu Z, Dinh-Xuan AT.
    Oncol Rep; 2014 Dec; 32(6):2795-802. PubMed ID: 25333508
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis.
    Kroll J, Epting D, Kern K, Dietz CT, Feng Y, Hammes HP, Wieland T, Augustin HG.
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H893-9. PubMed ID: 19181962
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fasudil inhibits lung carcinoma-conditioned endothelial cell viability and migration.
    Zhang Z, Ren JH, Li ZY, Nong L, Wu G.
    Oncol Rep; 2012 May; 27(5):1561-6. PubMed ID: 22344855
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Rho kinase inhibitor fasudil augments the number of functional endothelial progenitor cells in ex vivo cultures.
    O E, Ahn HY, Kim HK, You JC, Shin JC, Joe YA.
    Int J Mol Med; 2011 Sep; 28(3):357-63. PubMed ID: 21567077
    [Abstract] [Full Text] [Related]

  • 11. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells.
    Ogata S, Morishige K, Sawada K, Hashimoto K, Mabuchi S, Kawase C, Ooyagi C, Sakata M, Kimura T.
    Int J Gynecol Cancer; 2009 Dec; 19(9):1473-80. PubMed ID: 19955921
    [Abstract] [Full Text] [Related]

  • 12. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
    Xia Y, Cai XY, Fan JQ, Zhang LL, Ren JH, Chen J, Li ZY, Zhang RG, Zhu F, Wu G.
    Mol Cancer Ther; 2015 Jul; 14(7):1582-90. PubMed ID: 25934709
    [Abstract] [Full Text] [Related]

  • 13. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
    Zhu F, Zhang Z, Wu G, Li Z, Zhang R, Ren J, Nong L.
    Med Oncol; 2011 Jun; 28(2):565-71. PubMed ID: 20300976
    [Abstract] [Full Text] [Related]

  • 14. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
    Ying H, Biroc SL, Li WW, Alicke B, Xuan JA, Pagila R, Ohashi Y, Okada T, Kamata Y, Dinter H.
    Mol Cancer Ther; 2006 Sep; 5(9):2158-64. PubMed ID: 16985048
    [Abstract] [Full Text] [Related]

  • 15. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L, Li G, Li R, Liu Q, He Q, Zhang J.
    Cancer Biol Ther; 2010 Jun 01; 9(11):875-84. PubMed ID: 20364104
    [Abstract] [Full Text] [Related]

  • 16. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.
    Sulochana KN, Fan H, Jois S, Subramanian V, Sun F, Kini RM, Ge R.
    J Biol Chem; 2005 Jul 29; 280(30):27935-48. PubMed ID: 15923192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y, Cai X, Fan J, Zhang L, Li Z, Ren J, Wu G, Zhu F.
    Anticancer Drugs; 2017 Jun 29; 28(5):514-521. PubMed ID: 28225457
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.